Zonulin as a Potential Therapeutic Target in Microbiota-Gut-Brain Axis Disorders: Encouraging Results and Emerging Questions

Veres-Székely, Apor and Szász, Csenge and Pap, Domonkos and Szebeni, Beáta and Bokrossy, Péter and Vannay, Ádám (2023) Zonulin as a Potential Therapeutic Target in Microbiota-Gut-Brain Axis Disorders: Encouraging Results and Emerging Questions. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 24 (8). No.-7548. ISSN 1661-6596 (print); 1422-0067 (online)

Preview

Text ijms-24-07548-v2 (1).pdf Available under License Creative Commons Attribution. Download (2MB) | Preview

Abstract

The relationship between dysbiosis and central nervous diseases has been proved in the last 10 years. Microbial alterations cause increased intestinal permeability, and the penetration of bacterial fragment and toxins induces local and systemic inflammatory processes, affecting distant organs, including the brain. Therefore, the integrity of the intestinal epithelial barrier plays a central role in the microbiota-gut-brain axis. In this review, we discuss recent findings on zonulin, an important tight junction regulator of intestinal epithelial cells, which is assumed to play a key role in maintaining of the blood-brain barrier function. In addition to focusing on the effect of microbiome on intestinal zonulin release, we also summarize potential pharmaceutical approaches to modulate zonulin-associated pathways with larazotide acetate and other zonulin receptor agonists or antagonists. The present review also addresses the emerging issues, including the use of misleading nomenclature or the unsolved questions about the exact protein sequence of zonulin.

Actions (login required)

Edit Item